Abstract:Background: IPoC possesses a preventive effect against IR injury in healthy myocardium, but IPoC's protective effect on atherosclerotic myocardium is controversial. The current investigation aims to determine whether IPoC remains protective in atherosclerotic myocardium subjected to ischemia-reperfusion (IR) injury; to explore the specific mechanisms by which IPoC exerts cardioprotection; to explore whether HIF-1 upregulation combined with IPoC could further the provide cardioprotection; and to gaze at the specific mechanism whereby combined treatment expert the cardioprotection. Methods: ApoE-/- mice fed with a high-fat diet (HFD) were used to develop a model of atherosclerosis. The myocardial IR model was induced by occlusion of the left anterior descending (LAD) artery for 45 min, followed by reperfusion for 120 min. The protection of IPoC in both healthy and atherosclerotic myocardium was evaluated by measuring oxidative stress, apoptosis, infarct size, pathology, mitochondrial dysfunction and morphology of myocardium. The specific mechanism by which IPoC exerts cardioprotection in healthy and atherosclerotic myocardium was observed by measuring the expression of proteins involved in HIF-1, APMK and RISK pathways. The effect of HIF-1α overexpression on the cardioprotection by IPoC was observed by intravenous AAV9 -HIF-1α injection. Results: In healthy ischemic myocardium, IPoC exerted myocardial protective effects (antioxidant, anti-apoptosis, and improved mitochondrial function) through the activation of HIF-1, AMPK and RISK pathways. In atherosclerotic ischemic myocardium, IPoC exerted cardioprotection only through the activation of HIF-1 pathway; however, HIF-1 overexpression combined IPoC restored the activation of AMPK and RISK pathways, thereby further alleviating the myocardial IR injury. Conclusions: In the atherosclerotic state, the HIF-1 pathway is the intrinsic mechanism by which IPoC exerts cardioprotective effects. The combination of HIF-1 upregulation and IPoC has a significant effect in reducing myocardial injury, which is worth being promoted and advocated. In addition, HIF-1-AMPK and HIF-1-RISK may be two endogenous cardioprotective signalling pathways with great value, which deserve to be thoroughly investigated in the future.

iASPP protects the heart from ischemia injury by inhibiting p53 expression and cardiomyocyte apoptosis

Mild Therapeutic Hypothermia Protects the Brain from Ischemia/Reperfusion Injury through Upregulation of iASPP.

Ipla2β Contributes to ER Stress-Induced Apoptosis During Myocardial Ischemia/Reperfusion Injury

Upregulation of Iaspp Ameliorates Hypoxia/reoxygenation-Induced Apoptosis and Oxidative Stress in Cardiomyocytes by Upregulating Nrf2 Signaling

PCSK9 Knockdown Can Improve Myocardial Ischemia/Reperfusion Injury by Inhibiting Autophagy

Deletion of ASPP1 in myofibroblasts alleviates myocardial fibrosis by reducing p53 degradation

Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB.

PTB domain and leucine zipper motif 1 (APPL1) inhibits myocardial ischemia/hypoxia-reperfusion injury via inactivation of apoptotic protease activating factor-1 (APAF-1)/Caspase9 signaling pathway

Iaspp, A Previously Unidentified Regulator Of Desmosomes, Prevents Arrhythmogenic Right Ventricular Cardiomyopathy (Arvc)-Induced Sudden Death

Isthmin-1 Alleviates Cardiac Ischaemia/reperfusion Injury Through Cgmp-Pkg Signalling Pathway

Iasppsv Antagonizes Apoptosis Induced by Chemotherapeutic Agents in MCF-7 Cells and Mouse Thymocytes

The mechanism and targeted intervention of the HIF-1 pathway in improving atherosclerotic heart's sensitivity to ischemic postconditioning

Isthmin-1 alleviates cardiac ischemia/reperfusion injury through cGMP-PKG signaling pathway

Inhibitor of apoptosis stimulating protein of p53 protects against MPP+-induced neurotoxicity of dopaminergic neurons

Oncogene Iaspp Enhances Self‐renewal of Hematopoietic Stem Cells and Facilitates Their Resistance to Chemotherapy and Irradiation

Inhibition of Poly (Adp-Ribose) Polymerase and Inducible Nitric Oxide Synthase Protects Against Ischemic Myocardial Damage by Reduction of Apoptosis

iASPP on apoptosis in breast cancer cells which expressed wild type p53

Nuclear Iaspp Determines Cell Fate by Selectively Inhibiting Either P53 or NF-κB

PTPIP51 Regulates Mouse Cardiac Ischemia/reperfusion Through Mediating the Mitochondria-Sr Junction

Apelin-13 Protects the Heart Against Ischemia-Reperfusion Injury Through Inhibition of Er-Dependent Apoptotic Pathways in A Time-Dependent Fashion

RP105-PI3K–Akt Axis: A Potential Therapeutic Approach for Ameliorating Myocardial Ischemia/reperfusion Injury